SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (685)8/31/2000 1:11:55 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
(peeking around the corner, afraid of catching an "incoming").........

Looks like the seller may be finished? Geeeeze, that was a ton of shares.



To: scaram(o)uche who wrote (685)8/31/2000 1:18:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
NewsMakers in the Biotech Industry

The BTRN presentation is at 2:20. The blurb that describes the Presenting Companies includes, for BTRN, mention of (1) plans to release phase II results in 4Q00 for MEDI-507, (2) ongoing clinical trials with AlloMune in kidney transplantation and refractory lymphoma, and (3) porcine-to-human XenoMune partnered with Novartis.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News